Klotho Neurosciences Acquires Greenland Mines Corp: Transformational Asset for Shareholders

Key Points of the Transaction

• Klotho Neurosciences, Inc. (Nasdaq: KLTO) has announced the acquisition of Greenland Mines Corp. (GMC), granting it control over one of the world’s largest undeveloped palladium, gold, and platinum deposits – the Skaergaard Project in Southeast Greenland.
• The transaction gives shareholders direct ownership in this asset, valued at approximately \$68 billion in gross, undiscounted in-situ metal value.
• Post-acquisition, the company will operate two divisions:
  • Natural Resources – focused on mining and development of the Skaergaard Project
  • Cell and Gene Therapy – including Klotho’s KLTO-202 primary indication for ALS
• The leadership from Greenland Mines, led by CEO Bo Møller Stensgaard, will join Klotho’s management team, and one new Board member will be added.
• Klotho Neurosciences will rebrand as Greenland Mines, with a ticker change planned for late March 2026. No action required from current shareholders; shares will be automatically updated.

Details of Skaergaard Project

• The Skaergaard deposit is a geological phenomenon, discovered in 1935 and extensively studied by leading institutions.
• According to the 2022 NI 43-101 Technical Report (~45,000 meters of diamond drilling), the Total Indicated and Inferred Resource is:
  • 364.37 million tons at 2.17 g/t PdEq
  • 158.95 million tons Indicated at 2.22 g/t PdEq
  • 25.4 million ounces of palladium equivalent (Moz PdEq) and 23.5 million ounces of gold equivalent (Moz AuEq)
• The deposit is open in all directions, with mineralization confirmed beneath glaciers and plateaus, suggesting further expansion potential.
• Site access is established via licensed airstrip, helicopter logistics, and seasonal sea access. The project covers 877 km² with three mineral exploration licenses.
• Over \$100 million in historical investment would be required to replicate prior exploration work.
• The project is fully permitted for exploration, with environmental and metallurgical studies underway.

Shareholder Considerations & Price Sensitive Information

• The transaction consideration is payable in convertible preferred stock, conversion subject to shareholder approval. On an as-converted basis, Greenland Mines Corp. will own approximately 93% of fully diluted shares outstanding.
• The acquisition is expected to be treated as a reverse merger for accounting purposes, potentially impacting financial statements and valuation.
• The size and quality of the Skaergaard resource (with a gross in-situ value of \$68 billion) could significantly change the company’s trajectory and share value, making this a potentially price-moving event.
• The deposit’s resource estimate is believed to be conservative, with consistent drilling results and potential for further expansion, adding upside risk for investors.

Strategic Importance & Market Impact

• Palladium is critical for automotive emissions control, with 84% of global demand going to catalytic converters in gasoline and hybrid vehicles. The U.S. auto sector relies almost entirely on palladium for Clean Air Act compliance.
• Supply Chain Risks: 75–80% of global palladium comes from Russia and South Africa. Russia alone accounts for 40–45% of primary production. This leaves U.S. and European manufacturers exposed to geopolitical risks.
• Platinum faces similar risks, with 70% sourced from South Africa and 10–15% from Russia. It is essential for refining, medical instruments, hydrogen fuel cells, and other clean energy technologies.
• The Skaergaard resource (17.15 Moz palladium, 6.83 Moz gold) equals 13–15 years of total U.S. palladium consumption, offering a credible Western alternative to Russian and South African supply.
• Additional Critical Metals: Gallium (semiconductors, 5G, EVs, radar), vanadium (high-strength steel, batteries), both designated as critical minerals by U.S. and EU, are present in the deposit. Global supply for these is dominated by China, Russia, and South Africa, so Western supply from Skaergaard is highly strategic.
• Gold provides liquidity and hedging, strengthening project economics.
• These factors significantly enhance the asset’s robustness and diversification, potentially stabilizing revenue against commodity price fluctuations.

Company Overview

Klotho Neurosciences, Inc. is a Nasdaq-listed company now with two operating divisions: Natural Resources (Skaergaard Project) and Cell & Gene Therapy (ALS). Led by a multidisciplinary team in mining, geology, biotech, and capital markets, the company is positioned as a unique Western champion in critical mineral supply security.

Risks and Forward-Looking Statements

This transaction is subject to several risks and uncertainties. Mineral Resource Estimates are not Mineral Reserves and do not have demonstrated economic viability. In-situ metal values are illustrative and do not account for mining recoveries, losses, costs, royalties, taxes, or permitting. No preliminary economic assessment, pre-feasibility, or feasibility study has been completed, and there is no certainty that an economically viable mining operation can be established.

Forward-looking statements in this press release are subject to change based on future events, business execution, regulatory environment, and other risks. Investors should refer to SEC filings for detailed risk disclosures.

Contact Information

Investor Contact and Corporate Communications: [email protected]

Disclaimer

This article is for informational purposes only and does not constitute investment advice. The information is based on public disclosures as of March 4, 2026. Actual results and future events may differ materially due to risks discussed herein and in SEC filings. Investors are encouraged to conduct their own due diligence and consult with financial advisors before making any investment decisions.

View Klotho Neurosciences, Inc. Historical chart here